Art

J-GLOBAL ID：200902218342993785   Reference number：04A0660921

Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up study

アレンドロネートは骨粗しょう症を有する閉経後日本人女性に於ける椎骨骨折のリスクを低下させる:3年間の追跡調査

Author (9)： KUSHIDA K (Hamamatsu Univ. School of Medicine, Hamamatsu, JPN) ,  SHIRAKI M (Res. Inst. and Practice for Involutional Diseases, Nagano, JPN) ,  NAKAMURA T (Univ. Occupational and Environmental Health, Fukuoka, JPN) ,  KISHIMOTO H (Sanin Rosai Hospital, Tottori, JPN) ,  MORII H (Japan Osteoporosis Soc., Osaka, JPN) ,  YAMAMOTO K (Hakuai Hospital, Tottori, JPN) ,  KANEDA K (Bibai Rosai Hospital, Hokkaido, JPN) ,  FUKUNAGA M (Kawasaki Medical School, Okayama, JPN) ,  INOUE T (Aoyama General Hospital, Aichi, JPN)
Material： Journal of Bone and Mineral Metabolism  (JBMM)
Volume： 22  Issue： 5  Page： 462-468  Publication year： 2004 
JST Material Number： L0163A  ISSN： 0914-8779  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： *osteoporosis ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0660921&from=J-GLOBAL&jstjournalNo=L0163A") }}

JST classification (3)： Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of other drugs  (GW23020V)

Substance index (2)： Alendronate ,  Alphacalcidol

Reference (34)：

• ORIMO, H. Trends in the incidence of hip fracture in Japan, 1987-1997 : the third nationwide survey. J Bone Miner Metab. 2000, 18, 126-131
• FUJIWARA, S. Life time risk of osteoporosis-related bone fractures in a Japanese cohort. Osteoporosis Int. 1997, 7, suppl 2, 16
• SATO, M. Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest. 1991, 88, 2095-2105
• AZUMA, Y. Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models. Bone (NY). 1995, 16, 235-245
• LIBERMAN, UA. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med. 1995, 333, 1437-1443

Terms in the title (9)： アレンドロネート ,  骨粗しょう症 ,  閉経後 ,  日本人 ,  女性 ,  椎骨 ,  骨折 ,  リスク ,  追跡調査